CONSTITUENT REPORT
Carvacrol methyl ether
Carvacrol methyl ether is a methoxy aromatic monoterpene derivative found in thyme, savory, oregano-related, and other strongly aromatic essential oils. The source base for this constituent is strongest on identity, occurrence, and structure-activity context rather than on human-use efficacy. Accessible preclinical papers show two different but compatible themes: methylation of carvacrol weakens the free-phenol-driven antimicrobial effect seen with carvacrol itself, while the methyl ether can still participate in mixture-level insect-repellent or aroma-context activity. For AromaForge, the safest framing is as a well-defined aromatic marker with limited direct standalone wellness evidence.
Chemical identity and composition
PubChem and NIST align this constituent as C11H16O with InChIKey YVLHTQPPMZOCOW-UHFFFAOYSA-N and an IUPAC name of 2-methoxy-1-methyl-4-propan-2-ylbenzene. The synonym set spans carvacrol methyl ether, carvacryl methyl ether, O-methylcarvacrol, and p-cymene-2-ol methyl ether, which matters because essential-oil papers do not use one naming convention consistently.
Aroma and practical use
- Use the recorded herbal, spicy, leafy, citrusy, herbaceous, citrus descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A comparative antimicrobial study reported that carvacrol methyl ether and carvacryl acetate were not efficient antimicrobials against the tested bacteria, yeast, and fungus, while carvacrol was more active; the authors concluded that a free hydroxyl group is essential for that activity pattern.
A comparative antimicrobial study reported that carvacrol methyl ether and carvacryl acetate were not efficient antimicrobials against the tested bacteria, yeast, and fungus, while carvacrol was more active; the authors concluded that a free hydroxyl group is essential for that activity pattern.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A bioassay-guided isolation study on Adenosma buchneroides essential oil identified carvacrol methyl ether as one of the repellent compounds against Aedes albopictus, with reported minimum effective dosages in the active-compound range of 0.011-0.125 mg/cm2 across the isolated repellent set.
A bioassay-guided isolation study on Adenosma buchneroides essential oil identified carvacrol methyl ether as one of the repellent compounds against Aedes albopictus, with reported minimum effective dosages in the active-compound range of 0.011-0.125 mg/cm2 across the isolated repellent set.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A chemotype paper on wild Thymus pulegioides reported carvacrol methyl ether at 5.6-8.6% in carvacrol chemotypes, supporting its usefulness as an odor and composition marker in thyme-type oils.
A chemotype paper on wild Thymus pulegioides reported carvacrol methyl ether at 5.6-8.6% in carvacrol chemotypes, supporting its usefulness as an odor and composition marker in thyme-type oils.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A Satureja montana extract paper reported that the essential oil had antimicrobial activity while listing carvacrol, thymol, and carvacrol methyl ether among its major volatile constituents, which supports mixture-level occurrence but does not isolate this constituent's effect size.
A Satureja montana extract paper reported that the essential oil had antimicrobial activity while listing carvacrol, thymol, and carvacrol methyl ether among its major volatile constituents, which supports mixture-level occurrence but does not isolate this constituent's effect size.
This experimental finding does not establish benefit, dose or safety in people using this blend.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedPubChem's aggregated GHS view shows mixed notification outcomes, with most reports not meeting GHS hazard criteria but a minority carrying a warning classification for oral acute toxicity with hazard statement H302: harmful if swallowed.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No constituent-specific public dermal limit, phototoxicity threshold, or controlled human topical safety study was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Because the accessible activity data are preclinical or mixture-level, efficacy-style wellness claims would overstate the evidence base.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
alpha-ThujeneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
review · whole_oil
No source citation attached.
Read alpha-Thujene report →How the effects were investigated
Loss of the free phenolic hydroxyl group appears to diminish the proton-exchange and hydrophobicity-linked antimicrobial behavior associated with carvacrol.
Loss of the free phenolic hydroxyl group appears to diminish the proton-exchange and hydrophobicity-linked antimicrobial behavior associated with carvacrol.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- No isolated-compound human clinical study, constituent-specific dermal limit, or robust human exposure assessment was verified in this pass.
- The strongest direct mechanistic paper located here is negative-comparative antimicrobial work showing loss of activity relative to carvacrol, not a broad positive pharmacology program.
- Some positive activity contexts are mixture-level or insect-repellent models rather than human wellness endpoints, so transferability is limited.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.